Trials / Sponsors / Sarah Sammons, MD
Sarah Sammons, MD
Academic / Other · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor an Metastatic Breast Cancer, HER2 Low Breast Carcinoma, HER2-negative Breast Cancer | Phase 1 / Phase 2 | 2025-11-17 |
| Recruiting | DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs Breast Cancer, Breast Cancer Female, Metastatic Triple-Negative Breast Carcinoma | Phase 2 | 2024-01-08 |
| Terminated | Neoadjuvant Immunotherapy in Brain Metastases Brain Metastases, Adult | Phase 2 | 2020-11-04 |